Jun Zhu
Affiliations: | Pharmacy | University of South Carolina, Columbia, SC |
Google:
"Jun Zhu"Mean distance: 106866
Cross-listing: StructuralBiologyTree
Parents
Sign in to add mentor| Ikunobu Muramatsu | grad student | 1998 | Fukui Medical School |
| Linda P. Dwoskin | post-doc | 2000-2002 | University of Kentucky |
Children
Sign in to add trainee| Sarah E. Davis | grad student | University of South Carolina | |
| Matthew J. Strauss | grad student | 2016- | University of South Carolina |
| Adrian M. Gomez | grad student | 2014 | University of South Carolina |
| Narasimha Midde | grad student | 2014 | University of South Carolina |
| Pamela M. Quizon | grad student | 2014-2019 | University of South Carolina |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhu J, Cirincione AB, Strauss MJ, et al. (2024) Impact of HIV-1 Tat protein on methamphetamine-induced inhibition of vesicular monoamine transporter2-mediated dopamine transport and methamphetamine conditioned place preference in HIV-1 Tat transgenic mice. European Journal of Pharmacology. 177030 |
| Jimenez-Torres AC, Hastie JA, Davis SE, et al. (2024) . The Journal of Pharmacology and Experimental Therapeutics |
| Jiménez-Torres AC, Porter KD, Hastie JA, et al. (2024) Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter. International Journal of Molecular Sciences. 25 |
| Hammond HR, Eans SO, Cirino TJ, et al. (2023) SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice. Neuroimmune Pharmacology and Therapeutics. 3: 1-6 |
| Davis SE, Cirincione AB, Jimenez-Torres AC, et al. (2023) The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases. International Journal of Molecular Sciences. 24 |
| Davis SE, Ferris MJ, Ananthan S, et al. (2022) . The Journal of Pharmacology and Experimental Therapeutics |
| Strauss MJ, Porter KD, Quizon PM, et al. (2022) Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. Plos One. 17: e0275182 |
| Zhu J, Quizon PM, Wang Y, et al. (2022) SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice. Neuropharmacology. 109239 |
| Davis S, Zhu J. (2022) Substance abuse and neurotransmission. Advances in Pharmacology (San Diego, Calif.). 93: 403-441 |
| Adeniran C, Yuan Y, Davis SE, et al. (2021) Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat. Acs Chemical Neuroscience |